scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1011855857 |
P356 | DOI | 10.1007/BF00262326 |
P953 | full work available at URL | http://link.springer.com/content/pdf/10.1007/BF00262326.pdf |
http://link.springer.com/article/10.1007/BF00262326/fulltext.html | ||
http://link.springer.com/content/pdf/10.1007/BF00262326 | ||
P698 | PubMed publication ID | 7307229 |
P2093 | author name string | V. S. Sethi | |
J. C. Kimball | |||
P2860 | cites work | Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data | Q30558717 |
Biliary excretion of vincristine | Q34263753 | ||
A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine | Q34461054 | ||
Pediatric Clinical Pharmacology and the "Therapeutic Orphan" | Q39624019 | ||
CSTRIP, a Fortran IV Computer Program for Obtaining Initial Polyexponential Parameter Estimates | Q39780974 | ||
Vincristine neurotoxicity | Q39901026 | ||
Cytotoxic thresholds of vincristine in a murine and a human leukemia cell line in vitro | Q40618885 | ||
Pharmacokinetics of vincristine sulfate in adult cancer patients | Q42671013 | ||
Estimation of human body surface area from height and weight | Q47387886 | ||
Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. | Q52795932 | ||
The pharmacokinetics of [3H]-vincristine in man | Q67674473 | ||
Inhibitory and cytotoxic effects of Oncovin (Vincristine sulfate) on cells of human line NHIK 3025 | Q67856211 | ||
Comparative pharmacokinetics of coumarin anticoagulants. IV. Application of a three-compartmental model to the analysis of the dose-dependent kinetics of bishydroxycoumarin elimination | Q70099059 | ||
A sensitive radioimmunoassay for vincristine and vinblastine | Q71262856 | ||
Vincristine (NSC-67574) symposium--summary and prospectives | Q72279970 | ||
THE STATHMOKINETIC EFFECT OF VINCRISTIME | Q77157420 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pharmacokinetics | Q323936 |
P304 | page(s) | 111-115 | |
P577 | publication date | 1981-01-01 | |
P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
P1476 | title | Pharmacokinetics of vincristine sulfate in children | |
P478 | volume | 6 |
Q71822480 | An investigation of the mouse as a model for vincristine toxicity |
Q44820661 | Bone marrow CFU-GM and human tumor xenograft efficacy of three tubulin binding agents |
Q38700644 | Clinical pharmacology of cancer chemotherapy in children. |
Q38186752 | Pharmacokinetic evaluation of vincristine for the treatment of lymphoid malignancies |
Q39768346 | Pharmacokinetics of anticancer drugs in children |
Q40635772 | Pharmacokinetics of vincristine in children and adolescents with acute lymphocytic leukemia |
Q42668077 | Pharmacokinetics of vincristine, vinblastine, and vindesine in rhesus monkeys |
Q40218146 | Plasma and cerebrospinal fluid pharmacokinetics of vincristine and vincristine sulfate liposomes injection (VSLI, marqibo®) after intravenous administration in Non-human primates. |
Q67891361 | Sensitive method for the determination of vincristine in human serum by high-performance liquid chromatography after on-line column-extraction |
Q34551578 | The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics |
Q37521422 | The in silico child: using simulation to guide pediatric drug development and manage pediatric pharmacotherapy. |
Q38837538 | Thinking outside the shunt-sterile CSF malabsorption in pilocytic astrocytomas: case series and review of the literature |
Q38906405 | Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias. |
Q68234283 | Vincristine potentiates cytochalasin B-induced DNA fragmentation in vitro |
Q28374641 | Vincristine revisited |